Top Markets
Coin of the day
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Rang în acțiuni #39173
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Preț acțiune
$0.378
Ultima sincronizare: 2024-05-24
Capitalizare de piață
$618.41K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează NeuBase Therapeutics, Inc. (NBSE)

Categorie

Prețul NBSE cu capitalizarea de piață a B
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
NBSE
$0.378
Capitalizarea de piață a NeuBase Therapeutics, Inc.(NBSE)
Capitalizare de piață: $618.41K
În anul August 2026, NeuBase Therapeutics, Inc. are o capitalizare de piață de $618.41K. Acest lucru face ca NeuBase Therapeutics, Inc. să fie a 39173rd-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a NeuBase Therapeutics, Inc. din 2004 până în 2026
NBSE în comparație cu top 5 cele mai populare stocks
Prețul pentru NBSE Activul B Capitalizarea de piață a B Rezultate
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$3,343,238 $618.41K
$5.470T +884,454,463.65%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,730,484 $618.41K
$4.467T +722,350,064.17%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,551,581 $618.41K
$4.174T +675,021,304.38%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,261,661 $618.41K
$3.700T +598,322,901.89%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$1,744,708 $618.41K
$2.854T +461,562,929.50%